TP53 and prostate cancer: The cytotoxic effect of BA was assessed in two human prostate cancer cell lines: androgen-responsive LNCaP cells (possessing wild-type p53), and androgen-refractory DU145 cells harboring mutant p53 with higher constitutive NF-κB levels.